Not logged inGenomic Biomarkers Associated with Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma: Analysis of UNITE Study Data
Jindal, Tanya; Jiang, Cindy; Alhalabi, Omar; Nizam, Amanda; Nguyen, Charles; Talukder, Rafee; Bakaloudi, Dimitra; Davidsohn, Matthew; Freeman, Dory; Glover, Michael; Khaki, Ali Raza; Evans, Sean; Lemke, Emily; Bose, Rohit; Sim, Woogwang; Pywell, Cameron; Basu, Arnab; Kilari, Deepak; Barata, Pedro C.; Bilen, Mehmet A.; Zakharia, Yousef; Milowsky, Matthew I.; Shah, Sumit A.; Bellmunt, Joaquim; Grivas, Petros; Emamekhoo, Hamid; Davis, Nancy B.; Gupta, Shilpa; Hoimes, Christopher; Campbell, Matthew T.; Alva, Ajjai; Koshkin, Vadim S. .png)
Share.png)
SaveSomatic alterations of TP53 and MDM2 associated with response to enfortumab vedotin in patients with advanced urothelial cancerJindal, Tanya; Zhu, Xiaolin; Bose, Rohit; Kumar, Vipul; Maldonado, Edward; Deshmukh, Prianka; Shipp, Chase; Feng, Stephanie; Johnson, Michelle S.; Angelidakis, Austin; Kwon, Daniel; Borno, Hala T.; de Kouchkovsky, Ivan; Desai, Arpita; Aggarwal, Rahul; Fong, Lawrence; Small, Eric J.; Wong, Anthony; Porten, Sima; Chou, Jonathan; Friedlander, Terence; Koshkin, Vadim S. Share Save The 5-Hydroxymethylcytosine Landscape of Prostate CancerSjostrom, Martin; Zhao, Shuang G.; Levy, Samuel; Zhang, Meng; Ning, Yuhong; Shrestha, Raunak; Lundberg, Arian; Herberts, Cameron; Foye, Adam; Aggarwal, Rahul; Hua, Junjie T.; Li, Haolong; Bergamaschi, Anna; Maurice-Dror, Corinne; Maheshwari, Ashutosh; Chen, Sujun; Ng, Sarah W. S.; Ye, Wenbin; Petricca, Jessica; Fraser, Michael; Chesner, Lisa; Perry, Marc D.; Moreno-Rodriguez, Thaidy; Chen, William S.; Alumkal, Joshi J.; Chou, Jonathan; Morgans, Alicia K.; Beer, Tomasz M.; Thomas, George, V; Gleave, Martin; Lloyd, Paul; Phillips, Tierney; McCarthy, Erin; Haffner, Michael C.; Zoubeidi, Amina; Annala, Matti; Reiter, Robert E.; Rettig, Matthew B.; Witte, Owen N.; Fong, Lawrence; Bose, Rohit; Huang, Franklin W.; Luo, Jianhua; Bjartell, Anders; Lang, Joshua M.; Mahajan, Nupam P.; Lara, Primo N.; Evans, Christopher P.; Tran, Phuoc T.; Posadas, Edwin M.; He, Chuan; Cui, Xiao-Long; Huang, Jiaoti; Zwart, Wilbert; Gilbert, Luke A.; Maher, Christopher A.; Boutros, Paul C.; Chi, Kim N.; Ashworth, Alan; Small, Eric J.; He, Housheng H.; Wyatt, Alexander W.; Quigley, David A.; Feng, Felix Y. Share Save Share Save Share Save Loss of function mutations of an ETS repressor expand the ETS positive subset of prostate cancerBose, Rohit; Abida, Wassim; Karthaus, Wouter; Armenia, Joshua; Iaquinta, Phillip; Wongvipat, John; Doran, Michael; Hieronymus, Haley; Watson, Philip; Sullivan, Patrick; Liang, Yupu; Schultz, Nikolaus; Sawyers, Charles Share Save Pilot study of bevacizumab (Bev) in combination with docetaxel (T) and cyclophosphamide (C) as adjuvant treatment (AdjRx) for patients (pts) with early stage (ES) HER-2 normal breast cancer (BrCa) ICORG 08-10Gullo, G.; Kennedy, J.; Breathnach, O.; McCaffrey, J.; Keane, M.; Martin, M.; Gupta, R.; Leonard, G.; Calvert, P.; Donnellan, P.; Walshe, J.; Mc Dermott, E.; Cairney, S.; Bose, R.; Scott, K.; Hernando, A.; Parker, I.; Tryfonopoulos, D.; Moulton, B.; Crown, J. Share Save A role for the TGFβ-Par6 polarity pathway in breast cancer progressionViloria-Petit, Alicia M.; David, Laurent; Jia, Jun Yong; Erdemir, Tuba; Bane, Anita L.; Pinnaduwage, Dushanthi; Roncari, Luba; Narimatsu, Masahiro; Bose, Rohit; Moffat, Jason; Wong, John W.; Kerbel, Robert S.; O'Malley, Frances P.; Andrulis, Irene L.; wrana, Jeffrey L. Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}